Paper42410102
A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in Canada.
Binet M and 8 others. Eur J Hum Genet, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in Canada. Papers, record 42410102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42410102
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in Canada.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Genetic Testing | Major topic |
| Humans | |
| Canada | |
| Retrospective Studies | |
| Genetic Counseling |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31335339 | Update on amyotrophic lateral sclerosis genetics. | Curr Opin Neurol | 2019 | https://conductscience.org/library/papers/31335339 | PubMed |
| 2 | 32718499 | Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management. | Clin Lab Med | 2020 | https://conductscience.org/library/papers/32718499 | PubMed |
| 3 | 34569363 | Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices. | Amyotroph Lateral Scler Frontotemporal Degener | 2022 | https://conductscience.org/library/papers/34569363 | PubMed |
| 4 | 37691292 | Evidence-based consensus guidelines for ALS genetic testing and counseling. | Ann Clin Transl Neurol | 2023 | https://conductscience.org/library/papers/37691292 | PubMed |
| 5 | 38384337 | Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38384337 | PubMed |
| 6 | 39031772 | Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months. | Muscle Nerve | 2024 | https://conductscience.org/library/papers/39031772 | PubMed |
| 7 | 39947885 | Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications. | J Neurol Neurosurg Psychiatry | 2025 | https://conductscience.org/library/papers/39947885 | PubMed |
| 8 | 35896380 | Systematic evaluation of genetic mutations in ALS: a population-based study. | J Neurol Neurosurg Psychiatry | 2022 | https://conductscience.org/library/papers/35896380 | PubMed |
| 9 | 38587854 | Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial. | JAMA Pediatr | 2024 | https://conductscience.org/library/papers/38587854 | PubMed |
| 10 | 27893008 | Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists. | JAMA Neurol | 2017 | https://conductscience.org/library/papers/27893008 | PubMed |
| 11 | 39511709 | How the prospect of a clinical trial impacts decision-making for predictive genetic testing in ALS. | Amyotroph Lateral Scler Frontotemporal Degener | 2025 | https://conductscience.org/library/papers/39511709 | PubMed |
| 12 | 35027459 | Genetic testing in motor neurone disease. | Pract Neurol | 2022 | https://conductscience.org/library/papers/35027459 | PubMed |
| 13 | 29045374 | Perspective: Don't keep it in the family. | Nature | 2017 | https://conductscience.org/library/papers/29045374 | PubMed |
| 14 | 40280545 | Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis. | Am J Obstet Gynecol | 2025 | https://conductscience.org/library/papers/40280545 | PubMed |
| 15 | 37569314 | Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569314 | PubMed |
| 16 | 41661214 | Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/41661214 | PubMed |
| 17 | 36129998 | Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36129998 | PubMed |
| 18 | 33589474 | Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. | J Neurol Neurosurg Psychiatry | 2021 | https://conductscience.org/library/papers/33589474 | PubMed |
| 19 | 39572211 | Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. | J Neurol Neurosurg Psychiatry | 2025 | https://conductscience.org/library/papers/39572211 | PubMed |
| 20 | 37736067 | Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum Disorders. | Neurol Clin Pract | 2023 | https://conductscience.org/library/papers/37736067 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42829387 | Genomics cycle: discover, diagnose, interpret, act. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/42829387 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42410102
GET https://conductscience.org/api/papers/v1/42410102/references?page=2